Related Experiment Video
Updated: Aug 1, 2025

Surface Engineering of Pancreatic Islets with a Heparinized StarPEG Nanocoating
Published on: June 23, 2018
Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer
1Department of Developmental and Cell Biology, Chao Family Comprehensive Cancer Center, University of California Irvine, Irvine, California.
Abstract:
Several approaches for overcoming immunotherapy resistance in pancreatic and colorectal cancer syngeneic models were assessed using heparin and immunotherapy. Beneficial responses were attributed to heparin-induced vascular normalization, ensuing CD8+ T-cell infiltration, and M1 macrophage polarization, suggesting the potential for heparin-anchored therapies in cold tumors such as pancreatic cancer. See related article by Wei et al., p. 2525.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Psychoneuroimmunology: Diabetes and Cancer

